Status:
COMPLETED
Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)
Lead Sponsor:
French National Agency for Research on AIDS and Viral Hepatitis
Conditions:
Ulcer
Herpes Genitalis
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Herpes virus type 2 (HSV-2) infection - as a cofactor of human immunodeficiency virus (HIV) transmission - can be targeted by anti-herpetic specific drugs, either as a continuous prophylactic treatmen...
Detailed Description
Objectives. The proposed project is a randomised placebo-controlled, double-blinded, multicentric therapeutic trial evaluating the association of antiherpetic treatment to the syndromic treatment for ...
Eligibility Criteria
Inclusion
- Clinically confirmed ulcer
- Resident of city or planning to stay for 1 month
- Be a women
Exclusion
- Pregnant women
- Menstruating women
- Positive protein urine test
Key Trial Info
Start Date :
May 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2005
Estimated Enrollment :
449 Patients enrolled
Trial Details
Trial ID
NCT00158483
Start Date
May 1 2003
End Date
October 1 2005
Last Update
December 30 2008
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre MST/SIDA
Bangui, Central African Republic
2
WAPTCAS
Accra, Ghana
3
Kumasi Hospital, Service d'infectiologie
Kumasi, Ghana